First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Johanneke H.M.J.V. Vestjens, Karen Bolhuis et al.|The Lancet Oncology|2023Cited by 168
Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial GroupSanne Nieuwenhuizen, Hester J. Scheffer, A. Bruynzeel et al.|Cancers|2020Cited by 109
The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trialKaren Bolhuis, Rutger‐Jan Swijnenburg, Marinde J. G. Bond et al.|European Journal of Cancer|2023Cited by 14